What is the desired transferrin saturation target in adults, including goals for iron overload and iron‑deficiency anemia management?

Goal Transferrin Saturation in Adults

For iron deficiency anemia management, transferrin saturation (TSAT) <20% is diagnostic when ferritin is 46-99 ng/mL, while for iron overload in hemochromatosis, target TSAT <50% during induction and <50-60% during maintenance phase. 12

Iron Deficiency Anemia Context

Diagnostic Thresholds

• TSAT <20% serves as a confirmatory marker for iron deficiency when ferritin levels are equivocal (46-99 ng/mL) in patients without inflammation 1
• In inflammatory conditions, TSAT becomes less reliable as an indicator of true iron availability to bone marrow 3
• The diagnostic utility of TSAT is particularly important when ferritin is elevated due to inflammation but iron deficiency still exists 4

Treatment Monitoring

While guidelines focus primarily on ferritin targets for iron repletion, TSAT provides complementary information:

• Target TSAT >20% is generally considered adequate for erythropoiesis 5
• Some evidence suggests maintaining TSAT 30-50% may optimize outcomes in hemodialysis patients receiving erythropoietin, though this applies to a specific population 6
• Population data indicates optimal survival occurs with TSAT 24-40% in the general population 7

Important caveat: In chronic kidney disease and inflammatory states, TSAT becomes a poor indicator of iron availability because inflammation-induced changes in iron metabolism are opposite to those in pure iron deficiency 3. Serum iron may provide more useful information than TSAT in these contexts.

Iron Overload (Hemochromatosis) Context

Induction Phase Targets

The 2022 EASL guidelines provide the most authoritative recommendations for hemochromatosis management:

• TSAT <50% during induction phase (British Society for Haematology recommendation) 2
• Primary target remains ferritin 50 μg/L, with TSAT serving as a secondary monitoring parameter

Maintenance Phase Targets

• TSAT <50% (British Society for Haematology) 2
• TSAT <60% (Danish guideline) 2
• The variation reflects that TSAT is not the primary therapeutic target in hemochromatosis management—ferritin takes precedence

Critical distinction: Unlike iron deficiency where TSAT helps diagnose the condition, in hemochromatosis TSAT serves primarily as a monitoring parameter to avoid over-treatment. The focus remains on ferritin levels (50-100 μg/L maintenance range) 222

Clinical Algorithm

For Iron Deficiency:

1. Use TSAT <20% as diagnostic threshold when ferritin 46-99 ng/mL
2. During treatment, aim for TSAT >20% as minimum adequate level
3. In non-inflammatory conditions, optimal range appears to be 24-40%
4. Avoid relying on TSAT in CKD or inflammatory states—use ferritin and clinical response instead

For Iron Overload:

1. Target TSAT <50% during both induction and maintenance
2. Some guidelines accept <60% during maintenance
3. Ferritin remains the primary therapeutic target, not TSAT
4. Monitor TSAT to ensure adequate iron depletion without causing deficiency